Distinct HbA1c trajectories in a type 2 diabetes cohort (Q43433493)

23 November 2017

title

Distinct HbA1c trajectories in a type 2 diabetes cohort (English)

1 reference

23 November 2017

1 reference

Trynke Hoekstra

0 references

Jacqueline M Dekker

1 reference

23 November 2017

Giel Nijpels

1 reference

23 November 2017

Annette C Moll

1 reference

23 November 2017

Esther van 't Riet

1 reference

23 November 2017

Bettine C P Polak

1 reference

23 November 2017

M Ruth Mast

1 reference

23 November 2017

Danielle E M C Jansen

series ordinal

object named as

A P Danielle Jansen

1 reference

23 November 2017

Iris Walraven

1 reference

23 November 2017

Simone P Rauh

1 reference

23 November 2017

Petra J M Elders

1 reference

23 November 2017

Femke Rutters

1 reference

23 November 2017

author name string

Amber A W A van der Heijden

series ordinal

1 reference

23 November 2017

publication date

8 October 2014

1 reference

23 November 2017

1 reference

23 November 2017

1 reference

23 November 2017

1 reference

23 November 2017

page(s)

267-275

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Classifying developmental trajectories over time should be done with great caution: a comparison between methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Follow-up report on the diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Characteristics related to poor glycemic control in NIDDM patients in community practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Achievement of goals in U.S. diabetes care, 1999-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Evaluation of risk factors for development of complications in Type II diabetes in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Resource use and costs of type 2 diabetes patients receiving managed or protocolized primary care: a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Impact of long-term measures of glucose and blood pressure on the retinal microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0633-8

10.1007/S00592-014-0633-8

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference